ReviewMolecular biomedicine2022
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy.
Qingfang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
154 papers cite itlatest 60 shown
this paperpooled itcites it